Finding out you’re sick is hard enough. Finding out you have a disease shared by less than 1% of the population with no established treatment is something else entirely. Rare disease breaks the ...

Pelareorep-based treatment regimen recently granted Fast Track Designation in 2L KRAS-mutant MSS metastatic colorectal cancer, confirming its potential in this large indication SAN DIEGO, March 02, ...

At first glance, the European Commission’s Biotech Act proposal may appear as another sectoral initiative aimed at boosting innovation. On closer reading, however, it signals something far more ...

Last year was characterized by fewer but larger venture capital financings for biotech, with 2025’s top 10 private rounds bringing in nearly $4 billion collectively. As venture markets rebounded ...

Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company’s lead therapeutic cancer ...

Garima recently attended the Panchayat Aaj Tak Assam event, where she spoke about Zubeen Garg's mindset According to her, Zubeen had become increasingly aware of how quickly life passes Garima Saikia ...

Get personalized, AI-powered answers built on 27+ years of trusted expertise. Principal is the amount you borrow, and interest is the amount you pay to the lender as a charge for borrowing. To ...

Market analysts and brokerage firms have identified high-conviction trading ideas for the upcoming session, focusing on the IT, industrial, pharmaceutical, banking, and retail sectors. Top picks ...

CRISPR stocks offer high growth potential but are volatile and risky, suitable for aggressive investors. Beam Therapeutics uses a precise base-editing technique, differentiating it from other CRISPR ...